GO:2000630 positive regulation of miRNA metabolic process: Regulatory Network, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000630 describes any process that activates or increases the frequency, rate or extent of miRNA metabolic process, a biological_process ontology term.
• Positive regulation of miRNA metabolism is essential for fine-tuning gene expression, impacting development, differentiation, and disease.
• Key regulators include transcription factors such as p53, which modulates miRNA processing and function.
• miRNA metabolic dysregulation is implicated in cancer, metabolic dysfunction-associated steatohepatitis, and viral infections.
• Experimental approaches to study this process include CRISPR knockout, point mutation, knock-in, overexpression, and CRISPR library screening.
• EDITGENE provides comprehensive CRISPR services to dissect the causal roles of genes in positive regulation of miRNA metabolic process.
Description
The Gene Ontology (GO) term GO:2000630, positive regulation of miRNA metabolic process, refers to any process that activates or increases the frequency, rate or extent of the metabolic processing of microRNAs (miRNAs). miRNAs are small non-coding RNAs that post-transcriptionally regulate gene expression by base-pairing with target mRNAs, leading to translational repression or degradation. The positive regulation of miRNA metabolism is therefore a critical node in the control of gene expression networks, influencing diverse biological processes such as cell proliferation, differentiation, and apoptosis. Understanding how this process is regulated provides insights into normal physiology and disease mechanisms, including cancer and metabolic disorders. Researchers study this term to identify upstream regulators and downstream effectors, often using CRISPR-based models to manipulate candidate genes and assess their impact on miRNA levels and function.
positive regulation of miRNA metabolic process At A Glance
| GO ID | GO:2000630 |
|---|---|
| GO term | positive regulation of miRNA metabolic process |
| Ontology | biological_process |
| Synonym | positive regulation of microRNA metabolic process |
| Major function | Upregulation of miRNA production, processing, or stability |
| Related processes | miRNA transcription, pri-miRNA processing, pre-miRNA export, Dicer processing, RISC loading |
| Key regulators | p53, AP-1, EIF4AII, epigenetic modifiers |
| Disease relevance | Cancer, metabolic dysfunction-associated steatohepatitis, viral infections |
What Is GO:2000630?
According to the QuickGO definition, GO:2000630 encompasses any process that activates or increases the frequency, rate or extent of miRNA metabolic process. This includes steps such as miRNA transcription, processing, maturation, and turnover, as well as the regulation of these steps by specific factors. The term is a child of positive regulation of gene expression and is specific to microRNA metabolism.
Why Is positive regulation of miRNA metabolic process Important in Cell Biology?
Positive regulation of miRNA metabolic process is crucial because miRNAs act as master regulators of gene expression, and their dysregulation is linked to numerous diseases. For example, p53, a tumor suppressor, controls miRNA metabolism to modulate cell cycle and apoptosis, and its dysfunction contributes to cancer. In metabolic dysfunction-associated steatohepatitis, epigenetic regulation of thyroid hormone action affects miRNA processing. Moreover, viruses such as hepatitis C virus exploit liver-specific miR-122, and its positive regulation impacts viral replication. Thus, understanding this process offers therapeutic opportunities and biomarkers for disease.
• Controls gene expression networks by modulating miRNA abundance.
• Essential for development, differentiation, and homeostasis.
• Dysregulation is implicated in cancer, where miRNAs can act as oncogenes or tumor suppressors.
• Plays a role in metabolic diseases such as steatohepatitis.
• Influences viral replication, as seen with miR-122 and hepatitis C virus.
• Epigenetic modifications, such as DNA methylation, regulate miRNA expression.
• Provides targets for therapeutic intervention in various diseases.
• CRISPR-based models enable functional dissection of regulatory genes.
• High-throughput screening identifies novel regulators of miRNA metabolism.
• Bioinformatics tools help predict miRNA-mRNA interactions and regulatory networks.
What Happens During positive regulation of miRNA metabolic process?
Transcriptional Activation of miRNA Genes
In simple terms: The process often starts when transcription factors bind to miRNA gene promoters and increase their transcription.
Positive regulation of miRNA metabolic process frequently begins with enhanced transcription of miRNA genes. For example, the tumor suppressor p53 can activate the transcription of specific miRNAs, such as miR-34a, to mediate its tumor suppressive functions. Similarly, AP-1 proteins, which are regulated at the translational level, can influence miRNA expression. Epigenetic mechanisms, including DNA methylation, also modulate miRNA gene transcription; hypomethylation of miR-138 promoter increases its expression in cervical cancer. Thus, transcriptional activation is a key step in positively regulating miRNA metabolism.
Processing and Maturation of miRNA
In simple terms: After transcription, the primary miRNA transcript is processed into mature miRNA by a series of enzymatic steps.
The miRNA metabolic process includes the cleavage of primary miRNA (pri-miRNA) by the Drosha-DGCR8 complex in the nucleus, export of precursor miRNA (pre-miRNA) to the cytoplasm by Exportin-5, and further processing by Dicer to generate mature miRNA duplexes. Positive regulation can occur at these steps; for instance, eukaryotic translation initiation factor 4AII (EIF4AII) contributes to miR-122 regulation of hepatitis C virus replication, possibly by affecting miRNA processing or stability. Additionally, p53 can modulate miRNA processing through interactions with the Drosha complex.
Regulation of miRNA Stability and Turnover
In simple terms: The amount of miRNA in a cell also depends on how quickly it is degraded.
Positive regulation of miRNA metabolic process can also involve increased stability or decreased turnover of mature miRNAs. For example, miR-122 is a highly abundant liver-specific miRNA that is stabilized by specific RNA-binding proteins, and its positive regulation enhances hepatitis C virus replication. Conversely, factors that promote miRNA degradation would negatively regulate the process. The balance between synthesis and degradation determines steady-state miRNA levels, and positive regulators can tip this balance toward accumulation.
Functional Consequences of miRNA Upregulation
In simple terms: More miRNA leads to stronger repression of target mRNAs, affecting cellular behavior.
When miRNA metabolic process is positively regulated, the increased mature miRNA levels lead to enhanced repression of target mRNAs. This can result in altered cell proliferation, apoptosis, or differentiation. For instance, miR-138 upregulation in cervical cancer targets EZH2, inhibiting cell proliferation and epithelial-mesenchymal transition (EMT). In contrast, miR-122 upregulation promotes hepatitis C virus replication by binding to the viral genome. Thus, the functional outcome depends on the specific miRNA and cellular context.
Key Genes Involved in GO:2000630 positive regulation of miRNA metabolic process
The following genes and proteins are key players in the positive regulation of miRNA metabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Transcription factor that activates miRNA genes and modulates processing | Tumor suppression, cancer research |
| EIF4AII | Translation initiation factor involved in miR-122 regulation | Hepatitis C virus replication, miRNA processing |
| AP-1 | Transcription factor complex regulated at translational level | miRNA expression, cellular stress responses |
| EZH2 | Histone methyltransferase targeted by miR-138 | Cervical cancer proliferation and EMT |
| DICER1 | Ribonuclease that processes pre-miRNA to mature miRNA | miRNA maturation, gene silencing |
| DROSHA | RNase III enzyme that cleaves pri-miRNA | miRNA processing, nuclear steps |
| DGCR8 | Microprocessor complex component with Drosha | pri-miRNA recognition and cleavage |
| XPO5 | Exportin-5, mediates nuclear export of pre-miRNA | miRNA maturation, nucleocytoplasmic transport |
| AGO2 | Argonaute protein, core of RISC | miRNA effector complex, gene silencing |
| MIR138 | MicroRNA regulated by DNA methylation | Cervical cancer, EMT, proliferation |
| MIR122 | Liver-specific microRNA | Hepatitis C virus replication, liver metabolism |
| MIR34A | p53-regulated microRNA | Tumor suppression, apoptosis |
| DNMT1 | DNA methyltransferase | Epigenetic regulation of miRNA genes |
| THRA | Thyroid hormone receptor alpha | Metabolic dysfunction-associated steatohepatitis |
| THRB | Thyroid hormone receptor beta | Metabolic regulation, miRNA crosstalk |
| SMAD proteins | TGF-beta signaling effectors | miRNA regulation in fibrosis and cancer |
| MYC | Oncogenic transcription factor | miRNA activation and repression in cancer |
How Is positive regulation of miRNA metabolic process Regulated?
The positive regulation of miRNA metabolic process is itself subject to multiple layers of regulation. Transcription factors such as p53 and AP-1 can directly activate miRNA gene transcription. Epigenetic mechanisms, including DNA methylation and histone modifications, modulate miRNA expression; for example, DNA methylation of the miR-138 promoter silences its expression, so demethylation positively regulates it. Additionally, RNA-binding proteins and signaling pathways, such as thyroid hormone signaling, can influence miRNA processing and stability. Viral infections can also perturb miRNA metabolism, as seen with hepatitis C virus and miR-122. Thus, the process is controlled by a complex network of transcriptional, post-transcriptional, and epigenetic regulators.
positive regulation of miRNA metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MIR138 | Cervical cancer proliferation and EMT | KO or overexpression in HeLa cells |
| TP53 | Cancer (various types) | KO and point mutation in cancer cell lines |
| MIR122 | Hepatitis C virus replication | KO or overexpression in Huh7 cells |
| THRA/THRB | Metabolic dysfunction-associated steatohepatitis | KO or knock-in in hepatocytes |
| EIF4AII | HCV replication, miRNA processing | KO in liver cell lines |
Cancer
Dysregulation of miRNA metabolic process is a hallmark of cancer. Positive regulation of oncogenic miRNAs (oncomiRs) can promote tumorigenesis, while upregulation of tumor-suppressive miRNAs inhibits cancer progression. For instance, miR-138 is often downregulated in cervical cancer due to promoter hypermethylation; its re-expression via positive regulation targets EZH2 and suppresses proliferation and EMT. p53, a major tumor suppressor, positively regulates miR-34a and other miRNAs to induce cell cycle arrest and apoptosis, and loss of p53 function leads to decreased miRNA levels and cancer progression. Thus, targeting the positive regulation of miRNA metabolism offers therapeutic potential.
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Epigenetic regulation of thyroid hormone action in human metabolic dysfunction-associated steatohepatitis involves miRNA metabolic processes. Thyroid hormone receptors (THRA, THRB) regulate gene expression, and their crosstalk with miRNAs can influence lipid metabolism and inflammation. Positive regulation of specific miRNAs may contribute to disease pathogenesis or serve as compensatory mechanisms. Understanding these interactions could lead to new treatments for MASH.
Viral Infections
Hepatitis C virus (HCV) exploits the liver-specific miRNA miR-122 for its replication. Positive regulation of miR-122 metabolic process increases its abundance, which binds to the HCV 5' untranslated region and enhances viral RNA stability and translation. EIF4AII contributes to miR-122 regulation of HCV replication, highlighting the interplay between host miRNA metabolism and viral infection. Modulating miR-122 levels is a potential antiviral strategy.
Other Diseases
Altered miRNA metabolism has been implicated in neurodegenerative diseases, cardiovascular disorders, and immune dysfunction, although specific examples from the provided citations are limited. The general principle is that miRNAs fine-tune gene expression, and their dysregulation contributes to disease pathology.
From positive regulation of miRNA metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate miRNA metabolism? | CRISPR knockout of gene X followed by miRNA profiling |
| Does a specific point mutation in gene X affect miRNA processing? | CRISPR point mutation knock-in of the mutation |
| Does overexpression of gene X increase miRNA levels? | CRISPR activation (CRISPRa) or cDNA overexpression |
| Does a tagged version of gene X interact with miRNA processing complexes? | Knock-in of epitope tag (e.g., FLAG) at endogenous locus |
| Which genes regulate a specific miRNA? | Genome-wide CRISPR library screening with miRNA reporter |
| Does epigenetic modification of a miRNA promoter affect its expression? | CRISPR-dCas9-DNMT or TET for targeted methylation/demethylation |
How to Study the positive regulation of miRNA metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Small RNA sequencing | Mature miRNA abundance | Profiling changes in miRNA levels after perturbation |
| qRT-PCR | Specific miRNA levels | Validation of candidate miRNAs |
| CRISPR knockout | Loss-of-function of candidate gene | Testing if gene positively regulates miRNA metabolism |
| CRISPR activation (CRISPRa) | Gain-of-function of candidate gene | Testing if overexpression increases miRNA levels |
| In vitro processing assay | Enzymatic cleavage of pri/pre-miRNA | Mechanistic studies of Drosha/Dicer |
| Bisulfite sequencing | DNA methylation of miRNA promoters | Epigenetic regulation |
| ChIP-seq | Transcription factor binding to miRNA promoters | Identifying direct regulators |
| Luciferase reporter assay | miRNA activity on target 3'UTR | Functional validation of miRNA |
miRNA Expression Profiling
To study positive regulation of miRNA metabolic process, researchers quantify mature miRNA levels using small RNA sequencing, qRT-PCR, or microarray. These methods measure the output of the metabolic process and can identify miRNAs whose levels change upon genetic perturbation.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify positive regulators of miRNA metabolism. For example, a reporter cell line expressing a fluorescent protein under the control of a miRNA target site can be used to isolate regulators that increase miRNA activity.
Biochemical Assays for miRNA Processing
In vitro processing assays using nuclear or cytoplasmic extracts can measure pri-miRNA cleavage by Drosha or pre-miRNA processing by Dicer. These assays help dissect the molecular mechanisms of positive regulation.
Epigenetic Analysis
DNA methylation and histone modification status of miRNA gene promoters can be assessed by bisulfite sequencing and ChIP. These methods reveal epigenetic mechanisms that positively regulate miRNA transcription.
How CRISPR Can Be Used to Study GO:2000630 positive regulation of miRNA metabolic process
Knockout
CRISPR knockout (KO) of candidate genes is used to determine whether they are required for positive regulation of miRNA metabolic process. For example, KO of EIF4AII can assess its role in miR-122 regulation of HCV replication. KO of p53 can reveal its contribution to miRNA processing. KO models are essential for loss-of-function studies.
Point Mutation
CRISPR point mutation knock-in introduces specific amino acid changes to dissect functional domains. For instance, mutating phosphorylation sites in p53 can test their role in miRNA activation. Point mutations in EIF4AII can clarify its ATPase activity in miRNA regulation.
Knock-in
CRISPR knock-in of epitope tags (e.g., FLAG, HA) at endogenous loci allows for affinity purification and interaction studies. Tagging Drosha or DGCR8 can identify proteins that positively regulate miRNA processing. Knock-in of reporter genes (e.g., luciferase) under miRNA promoters enables high-throughput screening.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression is used to test gain-of-function. Overexpressing p53 can increase miR-34a levels. Overexpressing miR-138 in cervical cancer cells can suppress proliferation and EMT. Overexpression models are valuable for confirming positive regulation.
How EDITGENE Supports positive regulation of miRNA metabolic process Research
Researchers studying positive regulation of miRNA metabolic process-related genes often need to determine whether a candidate gene is causally involved in miRNA regulation or merely correlated with changes in miRNA levels. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation and functional validation, from single-gene knockout to genome-wide library screening.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of miRNA metabolic process research.
Frequently Asked Questions About positive regulation of miRNA metabolic process
What is GO:2000630 positive regulation of miRNA metabolic process?
GO:2000630 is a Gene Ontology term for any process that activates or increases the frequency, rate or extent of microRNA (miRNA) metabolic process, including transcription, processing, and stability.
What genes are involved in positive regulation of miRNA metabolic process?
Key genes include TP53, EIF4AII, AP-1, DICER1, DROSHA, DGCR8, XPO5, AGO2, and specific miRNAs such as MIR138 and MIR122.
How is positive regulation of miRNA metabolic process studied?
Researchers use small RNA sequencing, qRT-PCR, CRISPR knockout/activation, in vitro processing assays, and epigenetic analyses.
Why is positive regulation of miRNA metabolic process important in cancer?
Dysregulation of miRNA metabolism contributes to cancer; for example, p53 positively regulates tumor-suppressive miRNAs, and miR-138 upregulation inhibits cervical cancer proliferation.
What diseases are associated with miRNA metabolic process dysregulation?
Cancer, metabolic dysfunction-associated steatohepatitis, and viral infections such as hepatitis C are linked to altered miRNA metabolism.
Can CRISPR be used to study positive regulation of miRNA metabolic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional dissection of genes involved in miRNA regulation.
What is the role of p53 in miRNA metabolism?
p53 transcriptionally activates several miRNAs, including miR-34a, and modulates miRNA processing to mediate tumor suppression.
How does miR-122 regulate hepatitis C virus?
miR-122 binds to the HCV 5' UTR and enhances viral RNA replication; positive regulation of miR-122 metabolism increases HCV replication.
What are the epigenetic mechanisms regulating miRNA expression?
DNA methylation and histone modifications regulate miRNA gene promoters; for example, hypomethylation of miR-138 increases its expression.
What services does EDITGENE offer for miRNA research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to study positive regulation of miRNA metabolic process.
Conclusion
The positive regulation of miRNA metabolic process (GO:2000630) is a fundamental biological process that controls gene expression networks and impacts development, homeostasis, and disease. Key regulators such as p53, EIF4AII, and epigenetic modifiers modulate miRNA transcription, processing, and stability, with profound implications for cancer, metabolic diseases, and viral infections. Leveraging CRISPR-based models and advanced screening technologies, researchers can dissect the causal roles of specific genes and identify novel therapeutic targets. EDITGENE stands ready to support these efforts with comprehensive gene editing and bioinformatics services.
References
- 1. Chen R et al.. 2022. DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2.. BMC Cancer 22(1):488 PMID: 35505294
- 2. Naujack AM et al.. 2024. Epigenetic regulation of thyroid hormone action in human metabolic dysfunction-associated steatohepatitis.. Eur Thyroid J 13(5) PMID: 39312733
- 3. Liu J et al.. 2017. MicroRNA Control of p53.. J Cell Biochem 118(1):7-14 PMID: 27216701
- 4. Ahmed CS et al.. 2018. Eukaryotic translation initiation factor 4AII contributes to microRNA-122 regulation of hepatitis C virus replication.. Nucleic Acids Res 46(12):6330-6343 PMID: 29669014
- 5. Vesely PW et al.. 2009. Translational regulation mechanisms of AP-1 proteins.. Mutat Res 682(1):7-12 PMID: 19167516
- 6. Jopling CL et al.. 2006. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.. Cold Spring Harb Symp Quant Biol 71:369-76 PMID: 17381319
- 7. Afonso-Grunz F et al.. 2015. Principles of miRNA-mRNA interactions: beyond sequence complementarity.. Cell Mol Life Sci 72(16):3127-41 PMID: 26037721
- 8. Hirota T. 2018. [Epigenetic Regulation of Pharmacokinetic-related Genes in Human Tissues].. Yakugaku Zasshi 138(11):1391-1396 PMID: 30381647
